Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitis Central Retinal Vein Occlusion Rarely Complicates Ulcerative Colitis
Central retinal vein occlusion (CRVO) can rarely complicate the course of inflammatory bowel disease (IBD), according to a case series.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - May 22, 2019 Category: Opthalmology Tags: Gastroenterology News Source Type: news

What Causes Macrocephaly?
Discussion “Macrocephaly is defined as [an occipitofrontal circumference or head circumference, OFC ] of> 2 standard deviations above the mean or above the 97th percentage for a given age, and gender, or when serial measurement shows progressive enlargement, crossing of one or more major percentiles, or when there is an increase in OFC> 2 cm/month in the first 6 months of life.” Megalencephaly is enlargement of the brain parenchyma. The OFC should be measured using a non-elastic tape which surrounds the head along the line of the glabella and posterior occipital protrusion. There are ethnic differences f...
Source: PediatricEducation.org - May 20, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Research suggests revision to common view on how retinal cells in mammals process light
(Johns Hopkins Medicine) Johns Hopkins Medicine scientists say that new experiments with mouse eye tissues strongly suggest that a longstanding 'textbook concept' about the way a mammal's retina processes light needs a rewrite. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2019 Category: International Medicine & Public Health Source Type: news

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 15, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

Newly identified bacteria-killing protein needs vitamin A to work
(UT Southwestern Medical Center) UT Southwestern researchers identified a previously unknown bacteria-killing protein on the epidermis that requires vitamin A to work. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2019 Category: International Medicine & Public Health Source Type: news

Personalized 'Eye-in-a-Dish' models reveal genetic underpinnings of macular degeneration
(University of California - San Diego) Using stem cells derived from six people, UC San Diego School of Medicine researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants that cause age-related macular degeneration, a common cause of vision loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Vitamin B12 deficiency: Six B12-rich foods you should eat to keep symptoms at bay
VITAMIN B12 is a water-soluble vitamin essential for proper red blood cell formation. If you lack the vitamin, a deficiency can occur, and left untreated serious problems can develop. Eating B12-rich foods can help keep the condition at bay. (Source: Daily Express - Health)
Source: Daily Express - Health - May 7, 2019 Category: Consumer Health News Source Type: news

The Speed of Sound: Ultrasound for Retinal Detachment is about Ruling In, Not Ruling Out
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - May 1, 2019 Category: Emergency Medicine Tags: The Speed of Sound Source Type: news

Is Seaweed Healthy? Here ’s What Experts Say
Seaweed is a staple in many Asian cuisines, but many Americans still only encounter it when they go out for sushi. As a result, many diners don’t know what to make of it: Is seaweed healthy? Does it count as a vegetable? Are all kinds nutritionally the same? Miho Hatanaka, a Japanese-born registered dietitian who is based in Oregon, says the sea vegetable is worth getting to know. In the Japanese tradition, “people really attribute their health and longevity to seaweed, and even healthier skin and hair,” she says. Here’s what you need to know about eating seaweed. There are many types of edible sea...
Source: TIME: Health - April 30, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition Source Type: news

Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year. (Source: The Scientist)
Source: The Scientist - April 30, 2019 Category: Science Tags: News & Opinion Source Type: news

Earlier detection of diabetic retinopathy with smartphone AI
(Michigan Medicine - University of Michigan) Equipping a smartphone to capture retinal images and utilizing artificial intelligence to interpret them may help overcome barriers to ophthalmic screening for people with diabetes, new Kellogg Eye Center research shows. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 29, 2019 Category: Biology Source Type: news

Is Ghee Healthy? Here ’s What the Science Says
Ghee is a type of clarified butter used in the cuisines of India and the Middle East. Traditionally, it’s made by gently heating cow’s-milk butter until its water content evaporates and its milk solids can be skimmed and strained away, leaving behind only the liquid fat. “Clarified butter is very similar [to ghee], but it’s sometimes made using high heat, whereas ghee is simmered at 100 degrees or less,” says Chandradhar Dwivedi, a distinguished professor emeritus of pharmacology at South Dakota State University. While ghee takes longer to make than some other types of clarified butter, it ret...
Source: TIME: Health - April 22, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Diet/Nutrition Source Type: news

How Common Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Second Sight Medical releases early feasibility data on Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to the visual cortex in the brain, bypassing the eye and the optic nerve entirely. The company’s Argus II device, which uses a retinal implant to receive the camera’s signal, is already on the U.S. market. Interim data from a five-year early feasibility study, prese...
Source: Mass Device - April 11, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Featured Optical/Ophthalmic Second Sight Source Type: news

Gene therapy companies merge
A Montgomery County medical device company specializing in the precision delivery of cell and gene therapies is merging with a British biotechnology company that is developing gene therapies for retinal diseases. Financial terms of the deal involving Orbit Biomedical of Ambler and Gyroscope Therapeutics, which is based near London, are being kept confidential. The combined company will operate under the Gyroscope name and have its U.S. headquarters in Ambler. It will have a total 50 employees… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 11, 2019 Category: Health Management Authors: John George Source Type: news

Vitamins and Supplements Can ’t Replace a Balanced Diet, Study Says
Roughly 90% of American adults do not eat enough fruits and vegetables, but many are trying to make up for it by popping pills. According to the Council for Responsible Nutrition, 75% of U.S. adults take a dietary supplement of some kind. Multivitamins, many people believe, are a one-step way to get the nutrients they need. But new research published in the Annals of Internal Medicine suggests that vitamins and supplements may not be enough to keep you healthy. Nutrients consumed via supplements do not improve health and longevity as effectively as those consumed through foods, according to the study. While getting the rig...
Source: TIME: Health - April 8, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Diet/Nutrition Source Type: news

Retinal prion disease study redefines role for brain cells
Microglia may benefit, not damage, photoreceptors. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - March 27, 2019 Category: American Health Source Type: news

Retinal prion disease study redefines role for brain cells
(NIH/National Institute of Allergy and Infectious Diseases) National Institutes of Health scientists studying the progression of inherited and infectious eye diseases that can cause blindness have found that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice. In contrast, the study findings indicated that microglia might delay disease progression. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 27, 2019 Category: Infectious Diseases Source Type: news

Machines Treating Patients? It ’s Already Happening
Rayfield Byrd knows when it’s time to wake up every morning. The 68-year-old Oakland, Cal., resident hears a voice from the living room offering a cheery good morning. Except Byrd lives alone. A little after 8 a.m. each day, a small yellow robot named Mabu asks Byrd how he’s doing. Byrd has Type 2 diabetes and congestive heart failure, and about three years ago, he had surgery to implant a microvalve in his heart to keep his blood flowing properly. To stay healthy, he takes four medications a day and needs to exercise regularly. To make sure his heart is still pumping effectively, his doctor needs to stay on to...
Source: TIME: Health - March 21, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Artificial Intelligence Life Reinvented medicine Source Type: news

Manage your underactive thyroid with these essential nutrients
(Natural News) Hypothyroidism is a condition in which the thyroid gland does not produce enough thyroid hormones to keep the body functioning normally. Eating well-balanced meals is an important part of regulating a dysfunctional thyroid and the factors that contribute to the disease. Here are seven nutrients essential for hypothyroidism: Vitamin A: Vitamin A deficiency... (Source: NaturalNews.com)
Source: NaturalNews.com - March 19, 2019 Category: Consumer Health News Source Type: news

With single gene insertion, blind mice regain sight
(University of California - Berkeley) People left blind by retinal degeneration have one option: electronic eye implants. UC Berkeley neuroscientists have developed an alternative: gene therapy that, in tests, restored vision in blind mice. A gene for green opsin delivered via virus gave blind mice enough sight to discern patterns on an iPad at a resolution sufficient for humans to read. Given existing AAV eye therapies already approved, this new therapy could be ready for clinical trials in three years. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 15, 2019 Category: Biology Source Type: news

A short introduction to vitamin K deficiency
(Natural News) A person needs vitamins, so his or her body can grow healthy and strong. For the most part, many people strive to include vitamin-rich foods in their diet: A healthy meal usually has all the vitamins that your body needs in a day, which include: Vitamin A B-vitamins (thiamine, riboflavin, niacin, pantothenic acid, folate,... (Source: NaturalNews.com)
Source: NaturalNews.com - March 13, 2019 Category: Consumer Health News Source Type: news

Congo-Kinshasa: The Republic of Congo Starts Vaccinating 2.2 Million Children Against Measles and Rubella
[WHO] BRAZZAVILLE - March 5, 2019. Under the high patronage of the President of the Republic of Congo, His Excellency Denis SASSOU NGUESSO, the Government of Congo launched today a measles and rubella vaccination campaign, which aims to provide protection to more than 2.2 million children. This campaign, which targets boys and girls aged 9 months to 14 years will cover 43% of the country's population and will also include Vitamin A supplementation and mebendazole deworming for children aged 9 to 59 months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 13, 2019 Category: African Health Source Type: news

Do Gummy Vitamins Work? Here ’s What Experts Say
Gummy vitamins are increasingly popular—and not just for kids. By some estimates, adults now comprise up to 80% of the gummy vitamin market. “Pill fatigue” is one factor driving grownups toward gummies. If you have to take multiple supplements every day—and especially if you have problems swallowing capsules or tablets—gummies can make that chore easier (and tastier), finds a 2017 report from the AARP. But do gummy vitamins work the same as ordinary supplements? “It’s a lot harder to make a good gummy than it is to make a tablet or capsule,” says Dr. Tod Cooperman, president ...
Source: TIME: Health - March 13, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Diet/Nutrition Source Type: news

Retinal Microvascular Changes Identified in Alzheimer Disease
MONDAY, March 11, 2019 -- Individuals with Alzheimer disease (AD) have changes in the retinal microvasculature in the superficial capillary plexus (SCP) compared with those with mild cognitive impairment (MCI) and controls, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2019 Category: Pharmaceuticals Source Type: news

Increasingly complex mini-brains
(D'Or Institute for Research and Education) Scientists improved the initial steps of a standard protocol and produced organoids displaying regionalized brain structures, including retinal pigmented cells. The announcement was published today in BMC Developmental Biology by the D'Or Institute for Research and Education's team. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2019 Category: International Medicine & Public Health Source Type: news

Biogen deviates from neuroscience drugs with $800M acquisition
Biogen is expanding its portfolio outside of neuroscience, announcing Monday it is purchasing a British biotech firm focused on retinal disorders for $800 million. Biogen (Nasdaq: BIIB) is acquiring clinical stage gene therapy company Nightstar Therapeutics (Nasdaq: NITE), which is developing treatments for multiple retinal disorders. Its lead candidate, a treatment for a rare hereditary eye disorder that leads to blindness, is currently being tested in a Ph ase 3 trial. The deal is expected to… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 4, 2019 Category: American Health Authors: Allison DeAngelis Source Type: news

Retinal Layer Thinning in MS Advances With Disease Progression Retinal Layer Thinning in MS Advances With Disease Progression
Novel findings of inner, outer nuclear retinal layer atrophy add clues to the changes that occur with disease progression, independent of age.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 1, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Fingerprint and retinal security scans to be replaced with new biometric tool that scans, constantly monitors your heart using electromagnetic radiation
(Natural News) The world of technology may be a modern marvel, but each innovation seems to come with its own increasingly hefty price tag. The cost of personal privacy, in particular, has come to be a top concern — whether it be in the realm of social media or the latest password technology. Retinal and... (Source: NaturalNews.com)
Source: NaturalNews.com - March 1, 2019 Category: Consumer Health News Source Type: news

Second Sight Medical closes $35m rights offering
Second Sight Medical (NSDQ:EYES) said today that it closed a $34.6 million rights offering. The Sylmar, Calif.-based company said that it received subscriptions for a total of 45.8 million units, with a final subscription price of 72.4¢ per unit. Second Sight said that entities controlled by board chair Gregg Williams acquired a total of 41.4 million units for a total investment of approximately $30 million. The company said that it plans to issue 45.8 million shares of common stock and 45.8 million warrants to purchase an additional shares of the company’s stock at $1.47 per share. Warrants are set to expi...
Source: Mass Device - February 22, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Optical/Ophthalmic Wall Street Beat Second Sight Source Type: news

Medical News Today: Which foods are rich in vitamin A?
Vitamin A is an essential nutrient that plays a role in a range of bodily processes, such as immune function and vision. Here, we discuss 14 of the best food sources of vitamin A. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 19, 2019 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Sales of Philadelphia-born gene therapy product hit $27M during first year
In its first year, Luxturna — the first Food and Drug Administrative-approved gene therapy treatment for an inherited disease — generated $27 million in sales for Philadelphia-based Spark Therapeutics. Spark said it has shipped 75 vials of Luxturna, a one-time gene therapy used to treat adult and pediatric patients with v ision loss caused by inherited retinal dystrophy from a genetic mutation. The inherited retinal disorder, which leads to blindness if untreated, afflicts an estimated 1,000… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 19, 2019 Category: American Health Authors: John George Source Type: news

Ocugen wins orphan drug status for ocular gene therapy
The FDA has given Ocugen orphan drug status for a gene therapy designed to treat NR2E3 mutation-associated retinal degenerative disease. The Malvern, Penn.-based company’s OCU400 product includes an adeno-associated virum serotype 5 capsid that contains the gene for human nuclear hormone receptor NR2E3. Get the full story at our sister site, Drug Delivery Business News. The post Ocugen wins orphan drug status for ocular gene therapy appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 14, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Food & Drug Administration (FDA) Optical/Ophthalmic Pharmaceuticals Regulatory/Compliance ocugen Source Type: news

As Portland-area measles numbers hold steady, critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 13, 2019 Category: Pharmaceuticals Authors: Caitlin Mullen Source Type: news

As Portland-area measles numbers hold steady, critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

Critics call for Facebook to keep closer watch on anti-vaccination groups
Amid measles outbreaks and the World Health Organization announcing anti-vaxxers pose a global health threat, Facebook is drawing criticism for the proliferation of anti-immunization groups on the social media platform.   The Guardian reports that the groups promote alternatives to vaccines, like high doses of vitamin C to fight communicable diseases, or vitamin A to ward off measles. Some groups have tens of thousands of members and are closed, which means new members must be approved before joining.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration
DNA-alkylating agents are commonly used to kill cancer cells, but the base excision repair (BER) pathway they trigger can also produce toxic intermediates that cause tissue damage, such as retinal degeneration (RD). Apoptosis, a process of programmed cell death, is assumed to be the main mechanism of this alkylation-induced photoreceptor (PR) cell death in RD. Here, we studied the involvement of necroptosis (another programmed cell death process) and inflammation in alkylation-induced RD. Male mice exposed to a methylating agent exhibited a reduced number of PR cell rows, active gliosis, and cytokine induction and macropha...
Source: Signal Transduction Knowledge Environment - February 12, 2019 Category: Science Authors: Allocca, M., Corrigan, J. J., Mazumder, A., Fake, K. R., Samson, L. D. Tags: STKE Research Articles Source Type: news

Gambia: Meningitis Vaccination Campaign Gets Underway
[Foroyaa] The2019 campaign against Meningitis A with Vitamin A supplementation and deworming, has commenced nationwide on Saturday February 3rd 2019. The campaign is meant to protect children against Meningitis, vitamin A deficiency and worm infestation. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 5, 2019 Category: African Health Source Type: news

Vitamin or Mineral Supplements Don ’ t Prevent Dementia
B vitamins; beta carotene; vitamins C, D or E; zinc, copper or selenium — none proved effective in preventing cognitive decline. (Source: NYT Health)
Source: NYT Health - February 4, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Vitamins Antioxidants Selenium (Element) Dementia Source Type: news

Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
(Source: Johnson and Johnson)
Source: Johnson and Johnson - January 31, 2019 Category: Pharmaceuticals Source Type: news

New treatment target emerging for retinal damage
(Medical College of Georgia at Augusta University) Scientists at the Medical College of Georgia at Augusta University are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2019 Category: International Medicine & Public Health Source Type: news

Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Addition of Phase 3-Ready Clinical Program Orphan Drug Designation for Proliferative Vitreoretinopathy, A Potentially Blinding Disease with No Approved Treatment Initial Clinical Trial Results Expected in 2020 LEXINGTON, Mass., Jan. 29, 2019 -- (H... Biopharmaceuticals, Ophthalmology, Mergers & Acquisitions Aldeyra Therapeutics, Helio Vision, Vitreoretinopathy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2019 Category: Pharmaceuticals Source Type: news

Patch replaces damaged retinal cells
Researchers developed a biodegradable patch for replacing diseased cells in the eye with healthy ones. The findings provide the basis for preliminary safety tests of the method in people. (Source: NIH Research Matters)
Source: NIH Research Matters - January 29, 2019 Category: Research Source Type: news

What Are Common Causes of Blindness in Children?
Discussion According to the World Health Organization, about 1.3 billion people have some form of visual impairment. Most people with visual impairments are>50 years old, more are female than male, and more live in resource-limited areas than resource-rich areas. Most visual impairments are avoidable (80%) in all age groups with the leading causes globally and across ages being uncorrected refractive errors and cataracts. The most common causes of blindness are: Refractive errors, uncorrected Cataract Age-related macular degeneration Glaucoma Diabetic retinopathy Corneal opacity Trachoma The exact numbers vary by regi...
Source: PediatricEducation.org - January 28, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Nanoscope Receives NIH grants to recruit talent and advance optogenetic delivery platforms
(Nanoscope Technologies) Scientists at Nanoscope have developed gene therapy based on ambient light activatable Multi-Characteristic Opsin (MCO) for vision restoration in patients with retinal degeneration. NanoScope has been awarded several R01 grants from NIH for advancing both viral and non-viral delivery of MCO. Nanoscope recently received multiple Supplemental grants to recruit diverse talent for its Optogenetics and gene delivery programs. This is in addition to the recently awarded R01 and Phase2-SBIR grants to advance its optogenetics approach (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 25, 2019 Category: Biology Source Type: news

2019 Louis-Jeantet Prize for Medicine awarded to Botond Roska
(Institute of Molecular and Clinical Ophthalmology Basel) Botond Roska is awarded the 2019 Louis-Jeantet Prize for Medicine 2019, for the discovery of basic principles of visual information processing and the development of therapeutic strategies, such as gene therapy, to restore vision in retinal disorders. As one of the best-endowed awards in Europe (CHF 500,000 for each prize), the Louis-Jeantet Prizes foster scientific excellence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2019 Category: International Medicine & Public Health Source Type: news

Eritrea: NRS - Successful Measles and Rubella Vaccination Program
[Shabait] Massawa. -At an assessment meeting conducted in Massawa on 17 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Northern Red Sea region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 21, 2019 Category: African Health Source Type: news

Traumatic retinal detachment caused by nerf gun shot in a pediatric patient - Mandviwala MM, Sassani PP.
PURPOSE: To present a case of retinal detachment caused by a Nerf-gun shot in a pediatric patient. METHODS: Single case report. RESULTS: A 16-year-old white man presented with a nasal visual field deficit and floaters in his left eye for 1 ... (Source: SafetyLit)
Source: SafetyLit - January 16, 2019 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Eritrea: Successful Measles and Rubella Vaccination
[Shabait] Barentu -At an assessment meeting conducted in Barentu on 13 January it was reported that successful measles and rubella vaccination and Vitamin A distribution was conducted in the Gash Barka region through strong participation of the public and stakeholders. The vaccination program was conducted from 21 to 30 November 2018. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 16, 2019 Category: African Health Source Type: news